Navigation Links
BioMed Realty Trust Announces New Financing for Joint Venture With Prudential Real Estate Investors
Date:2/11/2009

SAN DIEGO, Feb. 11 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the completion of a refinancing of the secured acquisition and interim loan facility originally entered into in April 2007 by its joint venture with a fund managed by Prudential Real Estate Investors to acquire, among other properties, approximately 600,000 square feet of life science space in Cambridge, Massachusetts.

Proceeds from the refinancing were approximately $203 million, and were used to repay a portion of the outstanding indebtedness under the existing secured acquisition and interim loan facility. BioMed's share of the financed amount is approximately $41 million based on its 20% interest in the joint venture. BioMed repaid its remaining portion of the outstanding balance on the existing secured acquisition and interim loan facility by drawing on the company's $600 million unsecured line of credit. The term of the amended and restated secured acquisition and interim loan facility is two years, with an option to extend the maturity for an additional year. The facility is provided by a syndicate of lenders, for which KeyBank National Association is the administrative agent.

Commenting on the transaction, Kent Griffin, President and Chief Financial Officer of BioMed, said, "Completing the refinancing of the existing secured acquisition and interim loan facility with our partner PREI(R) represents the achievement of another milestone in managing our debt maturities. We are very pleased to have earned the support and commitment of our lending partners as demonstrated by this financing in an environment in which only the strongest sponsorships have access to credit."

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estat
'/>"/>

SOURCE BioMed Realty Trust, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. BioMed Realty Trust to Report 2008 Fourth Quarter and Year-End Results
2. ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Neural Cells
3. Origin BioMed Awarded Red Herring Top 100 Global Company
4. BioMed Realty Trust Extends Leases With Vertex Pharmaceuticals Through 2015
5. Bavarian Nordics Case Against Oxford BioMedica
6. BioLife Solutions Joins Prestigious Biomedical Excellence for Safer Transfusion Collaborative
7. BioMed Realty Trust Declares Fourth Quarter 2008 Common Stock and Preferred Stock Dividends
8. BioMed Realty Trust Promotes Kent Griffin to President
9. Alfred Mann Foundation for Biomedical Engineering Launches New Web Site Designed to Help University Researchers Bring Biomedical Advances to Market
10. BioFlorida Selects Collexis BiomedExperts.com as the Primary Professional Network for its 200 Member Companies and Organizations
11. Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...KJAVIK,Iceland,November24/PRNewswire-FirstCall/--d...eapprovalofallofits,"firstday"motionsbytheU.S.Bank...yCourt").deCODElastweekfiledavoluntarypetitionfor,...ewiththe,BankruptcyCourt. , Theordersissuedby...ateitsbusinessduringtheChapter11proceedings.Inpart...
(Date:11/24/2009)...MATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neuroge...cusedondevelopingandcommercializingnovelpainmanage...sidentandChiefExecutiveOfficer,isscheduledtopresen...obeheldDecember1-2,2009atTheNewYorkPalaceHotelinNe...,ChiefFinancialOfficer,willbeavailabletorespondtoq...
(Date:11/24/2009)...TTLE,Nov.24/PRNewswire/--BlueMarbleEnergyCorp.anno...entAuthority(OPDA)wererecentlyawarded$2millionbyWa...d(CERB)inaprivate/publicpartnershiptoconstructthes...nCounty,WA. ,, "Thisinvestmentwillsignificantly...reenjobstoLincolnCounty,"saidBlueMarbleEnergyCEOKe...
(Date:11/24/2009)...maryefficacyendpointhasbeenmetforpatientswithadvan...BECCITY,Nov.24/PRNewswire-FirstCall/-AEternaZentar...lbiopharmaceuticalcompanyfocusedonendocrinetherapy...aPhase2studywithitstargetedcytotoxicpeptideconjuga...orrecurrentendometrialcancer.Inapersonalizedhealth...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
... Richard D. Dyer, PhD, has been,appointed Executiv...a,Therapeutics, Inc., an early stage biotechnology...pies to treat bone diseases. "We are pleased to a...o,our management team. Dr. Dyer will oversee our p...r bone diseases; he also will lead our new,initiat...
... Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM )..., M.D., Ph.D., to its Board of Directors. Dr. Leid... sciences venture capital firm,has a distinguished...,biomedical and pharmaceutical sectors. Prior to j...Chief Operating Officer of the Global,Pharmaceutic...
...egin in fourth quarter -, SEATTLE, Oct. 4 ZymoGe...together with its collaborator Merck Serono, it,ha...ministration (FDA) on a,Special Protocol Assessmen...he investigational new drug atacicept for the trea...e of two clinical studies intended to form part,of...
Other Biology Technology:Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives 2Life Sciences Leader Joins Millennium Board of Directors 2Life Sciences Leader Joins Millennium Board of Directors 3ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis 2ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis 3
(Date:11/23/2009)...RONTO, November 23, 2009 - The time of day matters...o a new paper produced by a research team led by P...carborough,s vice-principal for research and colle...y at the St. George campus. , Capitalizing on ...plar tree, the research team examined how poplar t...
(Date:11/23/2009)...AMPAIGN, Ill. A new study provides "incontroverti...Toba on the island of Sumatra about 73,000 years a...les from the epicenter, researchers report. , Th...s of ash into the atmosphere, leaving a crater (no...ilometers long and 35 kilometers wide. Ash from th...
(Date:11/23/2009)...BIRMINGHAM, Ala. A new study by University of Ala...dy-mass index (BMI) and co-existing medical condit...urvival observed among African-Americans compared ...y is published online Nov. 23 in Cancer , a journ... indicates that although BMI and co-morbidity are ...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Hologic Expands Healthcare Investment in Asia 5563 1Hologic Expands Healthcare Investment in Asia 5563 2Hologic Expands Healthcare Investment in Asia 5563 3ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 1ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 2AccuVein Signs Multiple Country Distribution Agreement in Europe for Vein Illumination Device 5555 1AccuVein Signs Multiple Country Distribution Agreement in Europe for Vein Illumination Device 5555 2
...n monkeys has found that moderate exposure to alco...ivity to touch in the monkeys babies. In human chi...characteristics of the approximately 5 percent of ...Since these characteristics can lead to behavioral...reatment are important. Children who are sensitive...
...cuments malformations seen in an infant born to a ...olate mofetil (MMF), a widely used immunosuppressa...s suggest a specific birth defect pattern particul... to the fetus. The study was published in the Janu...Genetics, available online via Wiley InterScience ...
...ly known than the dangerous consequences of iron d...o cause problems. The exact origin of the genetic... (HH) has remained elusive. In a joint effort, res...atory (EMBL) and the University of Heidelberg, Ger...se. They report in the current issue of Cell Metab...
Other Biology News:Moderate prenatal exposure to alcohol and stress in monkeys can cause touch sensitivity 2Immunosuppressant further linked to birth defects 2Europe's most common genetic disease is a liver disorder 2
GeneSnap from SYNGENE
DISCOVERLIGHT 6XHIS ARRAY from Pierce Biotechnology, Inc.
Mouse Anti-XAGE2 Polyclonal Antibody, Unconjugated from Abnova Corporation
...recombinant or native proteins are used to immuniz...n protocol optimized in time, quantity of antigen ...nd the use of 2 animals per protocol in order to a...n a 77-day protocol is approximately 75 mL per rab...
Biology Products: